Evidence map›Paper›PMID 35962655›Full record

ArticleIndian pediatrics2022

Outcome of COVID-19 in Children With Tuberculosis: Single-Center Experience.

Sushant S Mane, Jyothi Janardhanan, Manas Pustake, Akshay Wanvat, Gazi Israil Khan, Rajratna Chopade

Abstract read
PubMed Full text at PMC
In one paragraph

Article in Indian pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Sushant S ManeCentre of Excellence for Pediatric TB and Department of Pediatrics, Grant Government Medical College and Sir JJ Group of Hospitals, Byculla, Mumbai, Maharashtra.
Jyothi JanardhananCentre of Excellence for Pediatric TB and Department of Pediatrics, Grant Government Medical College and Sir JJ Group of Hospitals, Byculla, Mumbai, Maharashtra.
Manas PustakeCentre of Excellence for Pediatric TB and Department of Pediatrics, Grant Government Medical College and Sir JJ Group of Hospitals, Byculla, Mumbai, Maharashtra. Correspondence to: Dr Manas Pustake, Centre of Excellence for Pediatric TB, Grant Government Medical College and Sir JJ Group of Hospitals, Byculla, Mumbai, Maharashtra. pustakemanas@gmail.com.
Akshay WanvatCentre of Excellence for Pediatric TB and Department of Pediatrics, Grant Government Medical College and Sir JJ Group of Hospitals, Byculla, Mumbai, Maharashtra.
Gazi Israil KhanCentre of Excellence for Pediatric TB and Department of Pediatrics, Grant Government Medical College and Sir JJ Group of Hospitals, Byculla, Mumbai, Maharashtra.
Rajratna ChopadeCentre of Excellence for Pediatric TB and Department of Pediatrics, Grant Government Medical College and Sir JJ Group of Hospitals, Byculla, Mumbai, Maharashtra.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the outcome of Coronavirus disease 2019 (COVID-19) infection in children and adolescents with tuberculosis.

methodsWe analyzed hospital records for the period May, 2020 to September, 2021 for children who were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcriptase-polymerase chain reaction (RT-PCR) positive or SARS-CoV-2 antibody positive. They were divided into two groups viz., those with tuberculosis (tuberculosis group) and those without tuberculosis (non-TB group). Demographic information, symptoms, and outcomes of COVID-19 were compared between the two groups.

resultsMedian (IQR) age of participants was 11 (8,14) and 4.5 (2,9) year for the tuberculosis and non-TB groups, respectively. 93.5% and 36.1% of children were asymptomatic in the tuberculosis and non-TB group, respectively. No variable in the study was significantly associated with COVID-19 positivity in children with tuberculosis. No difference was found in the outcomes of COVID-19 infection in children having tuberculosis.

conclusionsNo differences were noted in the outcomes of COVID-19 infection in children having tuberculosis.

Indexed as

COVID-19TuberculosisAdolescentChildHumansSARS-CoV-2

Identifiers

PMID35962655
PMCPMC9419137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.